Elias Hamida has a diverse work experience in the finance sector. Elias currently serves as Associate Director - Finance at OMass Therapeutics, a role they have held since 2022. Before that, they were Finance Partner - Global Health at ViiV Healthcare, a position they held since 2021. From 2015 to 2021, Hamida worked at GSK, where they held the roles of Commercial Finance Business Partner - Vaccines, Manager - Pricing & Analytics, and Finance Future Leaders Programme. During the latter role, they completed three-year rotations in 2017 as a Commercial Practices Auditor and in 2016 as an R&D Finance Partner. Additionally, from 2015 to 2021, Hamida was a Visiting Researcher at King Abdullah University of Science and Technology.
Elias Hamida is a member of CIMA with the ACMA, CGMA qualifications. Elias obtained their Master's Degree from the University of Cambridge in Computational Biology in 2015, and their Bachelor of Science (BS) in Biology from Imperial College London in 2014.
Sign up to view 1 direct report
Get started